Literature DB >> 31356555

NLRP3 Inflammasome in Acute Myocardial Infarction.

Adolfo G Mauro1,2, Aldo Bonaventura1,3, Eleonora Mezzaroma1,2,4, Mohammed Quader1,5,6, Stefano Toldo1,2,5.   

Abstract

Acute myocardial infarction (AMI) is associated with the induction of a sterile inflammatory response that leads to further injury. The NACHT, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome is a macromolecular structure responsible for the inflammatory response to injury or infection. NLRP3 can sense intracellular danger signals, such as ischemia and extracellular or intracellular alarmins during tissue injury. The NLRP3 inflammasome is primed and triggered by locally released damage-associated molecular patterns and amplifies the inflammatory response and cell death through caspase-1 activation. Here, we examine the scientific evidence supporting a role for NLRP3 in AMI and the available strategies to inhibit the effects of the inflammasome. Our focus is on the beneficial effects seen in experimental models of AMI in preclinical animal models and the initial results of clinical trials.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31356555     DOI: 10.1097/FJC.0000000000000717

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  29 in total

1.  NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases.

Authors:  Weijia Cheng; Can Cui; Gang Liu; Chenji Ye; Fang Shao; Ashim K Bagchi; Jawahar L Mehta; Xianwei Wang
Journal:  Cardiovasc Drugs Ther       Date:  2022-07-07       Impact factor: 3.727

2.  NLRP3 inflammasome as a novel therapeutic target for heart failure.

Authors:  Shuangcui Wang; Jiaqi Zhang; Yuli Wang; Xijuan Jiang; Maojuan Guo; Zhen Yang
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

3.  Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure.

Authors:  Yingdong Lu; Mi Xiang; Laiyun Xin; Yang Zhang; Yuling Wang; Zihuan Shen; Li Li; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Inhibition of GSDMD Activates Poly(ADP-ribosyl)ation and Promotes Myocardial Ischemia-Reperfusion Injury.

Authors:  Zheng-Hao Zhang; Zi-Guan Zhang; Min-Wei Chen; Ying Yang; Run-Jing Li; Jia-Jia Xu; Cui Yang; Yu-Ying Li; Hong-Wei Chen; Shi-Xiao Liu; Yan-Ling Li; Ping Luo; Yi-Jiang Liu; Wen-Bo Chen; Zhong-Gui Shan; Zheng-Rong Huang
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

5.  Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.

Authors:  Siyu Guo; Jiarui Wu; Wei Zhou; Xinkui Liu; Yingying Liu; Jingyuan Zhang; Shanshan Jia; Jialin Li; Haojia Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

6.  Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages.

Authors:  Carmelo Carmona-Rivera; Liam J O'Neil; Eduardo Patino-Martinez; William D Shipman; Chengsong Zhu; Quan-Zhen Li; Michelle L Kerns; Leandra A Barnes; Julie A Caffrey; Sewon Kang; Mariana J Kaplan; Ginette A Okoye; Angel S Byrd
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 8.551

Review 7.  Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.

Authors:  Aldo Bonaventura; Alessandra Vecchié; Tisha S Wang; Elinor Lee; Paul C Cremer; Brenna Carey; Prabalini Rajendram; Kristin M Hudock; Leslie Korbee; Benjamin W Van Tassell; Lorenzo Dagna; Antonio Abbate
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

Review 8.  NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis.

Authors:  Yang Liu; Chao Li; Honglin Yin; Xinrong Zhang; Yunlun Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-31       Impact factor: 2.629

Review 9.  Protein and Mitochondria Quality Control Mechanisms and Cardiac Aging.

Authors:  Rajeshwary Ghosh; Vishaka Vinod; J David Symons; Sihem Boudina
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

Review 10.  Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update.

Authors:  Aldo Bonaventura; Alessandra Vecchié; Antonio Abbate; Fabrizio Montecucco
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.